Cytomedix receives ISO 13485 and Canadian Medical Device Certification for Gaithersburg facility

Cytomedix, Inc. (NYSE:GTF) (the "Company" or "Cytomedix") today announced that it has received certification for the ISO 13485 Quality Management Standard for Medical Devices as well as Canadian Medical Device Certification for its Gaithersburg facility. The announcement certifies Cytomedix as a provider of high-quality devices for the medical industry and allows the Company to operate commercially in Europe and in Canada.

The ISO 13485 certification recognizes Cytomedix's compliance with medical industry standards. The ISO 13485 registration recognizes Cytomedix as a highly efficient, cost-effective and stable organization with advanced manufacturing processes to deliver product and service quality.

"Receipt of these certifications is the culmination of a great deal of cross-functional diligence and hard work by our employees. It is reflective of our mission to meet, if not exceed, all quality standards, and allows us to expand our global footprint and advance the international launch of our platelet rich plasma products," commented Martin P. Rosendale, President and CEO of Cytomedix. "Our customers in the medical industry understand the value of the ISO 13485 certification. We remain committed to the clinicians and patients we serve, and to continuously improving the effectiveness of the quality management system under which we operate."

SOURCE Cytomedix, Inc.